Login / Signup

Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myeloma.

Louisa ShackletonJames FayElizabeth SmythPhilip MurphySiobhan GlaveyJohn Quinn
Published in: EJHaem (2020)
Keyphrases
  • multiple myeloma
  • combination therapy
  • case report
  • open label
  • randomized controlled trial
  • acute lymphoblastic leukemia
  • diffuse large b cell lymphoma